Clinical trials
Hypertrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
139 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 5 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 9 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 10 |
| 2020 | 10 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 11 |
| 2024 | 11 |
| 2025 | 9 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 82 |
| Unknown status | 27 |
| Recruiting | 11 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 4 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AVAVA, Inc. | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Paulista University | 3 |
| David Smart | 2 |
| Karabuk University | 2 |
| Lindenwood University | 2 |
| Marymount University | 2 |
| McMaster University | 2 |
| Neodyne Biosciences, Inc. | 2 |
| University of British Columbia | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertrophy | 139 |
| Cicatrix | 13 |
| Hypertrophy, Left Ventricular | 10 |
| Cardiomyopathies | 9 |
| Cardiomyopathy, Hypertrophic | 8 |
| Heart Failure | 7 |
| Cardiovascular Diseases | 6 |
| Hypertension | 5 |
| Carcinoma, Hepatocellular | 4 |
| Keloid | 4 |
Trials
Showing 1 to 25 of 139. Each trial links to its page on Pharma Observatory.
39 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.